Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Paper
  • Published:

Bacterial Expression, Facile Purification and Properties of Recombinant Human Lymphotoxin (Tumor Necrosis Factor Beta)

Abstract

We have expressed a synthetic recombinant human TNF–β(rhTNF–β) gene in Escherichia coli to give rhTNF–β in a soluble, highly active and intact form. The specific activity of rhTNF–β purified in a single, convenient step from bacterial lysates was 3–5 × 107 units/mg on mouse L–929 cells. The cytostatic (growth inhibitory) and cytotoxic (cell killing) activities of rhTNF–β were compared in a variety of untransformed and transformed cell lines. In the absence of the protein synthesis inhibitor cycloheximide, two cell lines were growth inhibited by rhTNF–β but none were lysed. In the presence of cycloheximide, five out of eleven cell lines became sensitive to lysis by rhTNF–β, indicating that some but not all cells require uninterrupted protein synthesis in order to protect themselves from TNF–β cytotoxicity. Cell lines varied greatly in their sensitivity to rhTNF–β and a different pattern of response was seen in the cytostatic and cytotoxic assays.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Paul, N.L. and Ruddle, N.H. 1988. Lymphotoxin. Ann. Rev. Immunol. 6:407–438.

    Article  CAS  Google Scholar 

  2. Goeddel, D.V., Aggarwal, B.B., Gray, P.W., Leung, D.W., Nedwin, G.E., Palladino, M.A., Patton, J.S., Pennica, D., Shepard, H.M., Sugarman, B.J. and Wong, G.H.W. 1986. Tumour necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp. Quant. Biol. 51:597–609.

    Article  CAS  Google Scholar 

  3. Fiers, W., Brouckaert, P., Devos, R., Fransen, L., Leroux-Roels, G., Remaut, E., Suffys, P., Tavernier, P. Van der Heyden, J. and Van Roy, F. 1986. Lymphokines and monokines in anti-cancer therapy. Cold Spring Harbor Symp. Quant. Biol. 51:587–595.

    Article  CAS  Google Scholar 

  4. Sugarman, B.J., Aggarwal, B.B., Hass, P.E., Figari, I.S., Palladino, M.A. and Shepard, H.M. 1985. Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 230:943–945.

    Article  CAS  Google Scholar 

  5. Wang, A.M., Creasey, A.A., Ladner, M.B., Lin, L.S., Strickler, J., Van Arsdell, J.N., Yamamoto, R. and Mark, D.F. 1985. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149–154.

    Article  CAS  Google Scholar 

  6. Fransen, L., Ruysschaert, M.-R. Van der Heyden, J., and Fiers, W. 1986. Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. Cell. Immunol. 100:260–267.

    Article  CAS  Google Scholar 

  7. Mukavitz Kramer, S., Aggarwal, B.B., Eessalu, T.E., McCabe, S.M., Ferraiolo, B.L., Figari, I.S. and Palladino, M.A. 1988. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-α. Cancer Res. 48:920–925.

    PubMed  Google Scholar 

  8. Beutler, B., Mahoney, J., Le Trang, N., Pekala, P. and Cerami, A. 1985. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced Raw 264.7 cells. J. Exp. Med. 161:984–995.

    Article  CAS  Google Scholar 

  9. Torti, F.M., Dieckman, B., Beutler, B., Cerami, A. and Ringold, G.M. 1985. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229:867–869.

    Article  CAS  Google Scholar 

  10. Beutler, B., Milsark, I.W. and Cerami, A.C. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871.

    Article  CAS  Google Scholar 

  11. Collins, T., Lapierre, L.A., Fiers, W., Strominger, J.L. and Pober, J.S. 1986. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83:446–450.

    Article  CAS  Google Scholar 

  12. Pujol-Borrell, R., Todd, I., Doshi, M., Bottazzo, G.F., Sutton, R., Gray, D., Adolf, G.R., and Feldmann, M. 1987. HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin. Nature 326:304–306.

    Article  CAS  Google Scholar 

  13. Aderka, D., Novick, D., Hahn, T., Fischer, D.G. and Wallach, D. 1985. Increase in vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. Cell. Immunol. 92:918–925.

    Article  Google Scholar 

  14. Esparza, I., Mannel, D., Ruppel, A., Falk, W. and Krammer, P.H. 1987. Interferon-γ and lymphotoxin act synergistically to induce macrophage killing of tumor cells and schistosomula of schistosoma mansoni. J. Exp. Med. 166:589–594.

    Article  CAS  Google Scholar 

  15. Le, J. and Vilcek, J. 1987. Biology of disease—Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56:234–248.

    CAS  PubMed  Google Scholar 

  16. Munker, R., Gasson, J., Ogawa, M. and Koeffler, H.P. 1986. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323:79–82.

    Article  CAS  Google Scholar 

  17. Vogel, S.N., Douches, S.D., Kaufman, E.N. and Neta, R. 1987. Induction of colony stimulating factor in vivo by recombinant interleukin 1α and recombinant tumor necrosis factor α. J. Immunol. 138:2143–2148.

    CAS  PubMed  Google Scholar 

  18. Beutler, B. and Cerami, A. 1988. Tumor necrosis, cachexia, shock and inflammation: a common mediator. Ann. Rev. Biochem. 57:505–518.

    Article  CAS  Google Scholar 

  19. Nedwin, G.E., Naylor, S.L., Sakaguchi, A.Y., Smith, D., Jarrett-Nedwin, J., Pennica, D., Goeddel, D.V. and Gray, P.W. 1985. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13:6361–6373.

    Article  CAS  Google Scholar 

  20. Aggarwal, B.B., Eessalu, T.E. and Hass, P.I. 1985. Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon. Nature 318:665–667.

    Article  CAS  Google Scholar 

  21. Decker, T., Lohmann-Matthes, M.-L. and Gifford, G.E. 1987. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138:957–962.

    CAS  Google Scholar 

  22. Kriegler, M., Perez, C., DeFay, K., Albert, I., and Lu, S.D. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45–53.

    Article  CAS  Google Scholar 

  23. Rothstein, J.L. and Schreiber, H. 1988. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. USA 85:607–611.

    Article  CAS  Google Scholar 

  24. Gray, P.W., Aggarwal, B.B., Benton, C.V., Bringman, T.S., Henzel, W.J., Jarrett, J.A., Leung, D.W., Moffat, B., Ng, P., Svedersky, L.P., Palladino, M.A. and Nedwin, G.E. 1984. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis factor activity. Nature 312:721–724.

    Article  CAS  Google Scholar 

  25. Iserentant, D. and Fiers, W. 1980. Secondary structure of mRNA and efficiency of translation initiation. Gene 9:1–12.

    Article  CAS  Google Scholar 

  26. Hall, M.N., Gabay, J., Débarbouilté, M. and Schwartz, M. 1982. A role for mRNA secondary structure in the control of translation initiation. Nature 295:616–618.

    Article  CAS  Google Scholar 

  27. Porter, A.G., Bell, L.D., Adair, J., Catlin, G.H., Clarke, J., Davies, J.A. et al. 1986. Novel, modified β-interferons: gene cloning, expression and biological activity in bacterial extracts. DNA 5:137–148.

    Article  CAS  Google Scholar 

  28. Sancar, A., Hack, A.M. and Rupp, W.D. 1979. Simple method for the identification of plasmid-encoded proteins. J. Bacteriol. 137:692–693.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Schein, C.H. and Noteborn, M.H.M. 1988. Formation of soluble recombinant proteins in Eschenchia coli is favored by lower growth temperature. Bio/Technology 6:291–294.

    CAS  Google Scholar 

  30. Mark, D.F., Lu, S.D., Creasey, A.A., Yamamoto, R. and Lin, L.S. 1984. Site-specific mutagenesis of the human fibroblast interferon gene. Proc. Natl. Acad. Sci. USA 81:5662–5666.

    Article  CAS  Google Scholar 

  31. Aggarwal, B.B., Moffat, B. and Harkins, R.N. 1984. Human lymphotoxin-production by a lymphoblastoid cell line, purification and initial characterization. J. Biol. Chem. 259:686–691.

    CAS  PubMed  Google Scholar 

  32. Aggarwal, B.B., Kohr, W.J., Hass, P.E., Moffat, B., Spencer, S.A., Henzel, W.J., Bringman, T.S., Nedwin, G.E., Goeddel, D.V. and Harkins, R.N. 1985. Human tumor necrosis factor: production, purification and characterization. J. Biol. Chem. 260:2345–2354.

    CAS  Google Scholar 

  33. Ruggiero, V., Latham, K. and Baglioni, C. 1987. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells. J. Immunol. 138:2711–2717.

    CAS  PubMed  Google Scholar 

  34. Kirstein, M. and Baglioni, C. 1986. Tumor necrosis factor induces the synthesis of two proteins in human fibroblasts. J. Biol. Chem. 261:9565–9567.

    CAS  PubMed  Google Scholar 

  35. Defilippi, P., Poupart, P., Tavernier, J., Fiers, W. and Content, J. 1987. Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc. Natl. Acad. Sci. USA 84:4557–4561.

    Article  CAS  Google Scholar 

  36. Hudziak, R.M., Lewis, G.D., Shalaby, M.R., Eessalu, T.E., Aggarwal, B.B., Ullrich, A. and Shepard, H.M. 1988. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor α in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 85:5102–5106.

    Article  CAS  Google Scholar 

  37. Spriggs, D., Imamura, K., Rodriguez, C., Horiguchi, J. and Kufe, D.W. 1987. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl. Acad. Sci. USA 84:6563–6566.

    Article  CAS  Google Scholar 

  38. Tacon, W.C.A., Bonass, W.A., Jenkins, B. and Emtage, J.S. 1983. Expression plasmid vectors containing Escherichia coli tryptophan promoter transcriptional units lacking the attenuator. Gene 23:255–265.

    Article  CAS  Google Scholar 

  39. Ray, A. and Skurray, R. 1983. Cloning and polypeptide analysis of the leading region in F plasmid DNA transfer. Plasmid 9:262–272.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seow, HF., Goh, C., Krishnan, L. et al. Bacterial Expression, Facile Purification and Properties of Recombinant Human Lymphotoxin (Tumor Necrosis Factor Beta). Nat Biotechnol 7, 363–368 (1989). https://doi.org/10.1038/nbt0489-363

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0489-363

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing